CKChristina C. Kao

Christina C. Kao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christina C. Kao has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Amit D. Parulekar

    Section of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, Texas, USA

    3 shared publications
  • Anura Viswanath Kurpad

    Department of Physiology, St. John’s Medical College, St. John’s National Academy of Health Sciences (a Unit of CBCI Society for Medical Education), Bangalore 560034, Karnataka, India

    1 shared publication
  • Bastian Grande

    University Hospital Zurich, Zurich, Switzerland

    1 shared publication
  • Chao Yang

    Department of Blood Transfusion, The General Hospital of the PLA Rocket Force, Beijing, China

    1 shared publication
  • Elizabeth S. Guy

    Section of Pulmonary, Critical Care, and Sleep, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA

    1 shared publication
  • Emily B Hollister

    Department of Pathology and Immunology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 7 Texas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX

    1 shared publication

Latest Publications

  • Need for anticoagulation and use of direct oral anticoagulants in lung transplant recipients

    by Christina C. Kao, Tai Wang, Amit D. Parulekar

    Limited information is available about use of direct oral anticoagulants (DOACs) in lung transplant recipients (LTRs). The purpose of this study is to describe the indications and use of long-term anticoagulation, including the safety and tolerability of DOACs, in LTRs. This was a single-center retrospective study. LTRs who received therapeutic anticoagulation were identified. Patient characteristics, indications for treatment, and complications of therapy were obtained. A total of 203 patients underwent lung transplantation of which 118 patients (58.1%) had an indication for anticoagulation. Patients with an indication for anticoagulation were older than those without (59 ± 14 years versus 48 ± 17 years, p < 0.001) and were more likely to be male (72.0% versus 50.6%, p = 0.002). Of the patients with indication for anticoagulation, 74 (62.7%) received it. Fifty-one (68.9%) of patients receiving anticoagulation were treated with DOACs. In the patients receiving anticoagulation, there were 14 major bleeding events in 13 patients, of which 3 were receiving DOACs and the remainder were receiving heparin or warfarin. The need for anticoagulation is common in LTRs for both atrial arrhythmias and venous thromboembolism. However, many patients with atrial arrhythmias do not receive anticoagulation. The use of DOACs is well tolerated and safe in LTRs.


  • Open Access

    Pulmonary fibrosis combined with lung cancer following lung transplantation: should we do more?

    by Guilin Peng, Chao Yang, Mengyang Liu, Weixue Cui, Bastian Grande, Christina Kao, Piergiorgio Solli, George Makdisi, Xin Xu, Jianxing He

    Currently, lung transplantation is the standard of care for patients with end-stage lung disease, with interstitial lung disease (ILD) being the most common reason in the recent years In the other hand, in cases where stage II and III lung cancer have been identified following lung transplantation, long-term survival outcomes are poor when compared to lung cancer patients that have not received a lung transplant because the use of immunosuppressant and the problem of rejection and infection and the treatment of recurrence and so on. However, there is no statistical difference observed in stage I (pT1N0M0) patients. In this paper we report about a patient with ILD receiving left lung transplantation in the early time. A lesion of the right lung which was considered the normal ILD tissue and without enough attention. Post-transplant it showed progress and finally the whole right lung (native lung) was occupied by the tumor. Some ground glass changes could also be found in the transplanted lung several months later. A secondary lung transplant was performed for this patient, and there has been no postoperative recurrence thus far. For lung transplant patients with high-risk factors, effective surveillance methods are required for the early detection of lung cancer.


  • Pectoralis muscle area is associated with bone mineral density and lung function in lung transplant candidates

    by A. D. Parulekar, T. Wang, G. W. Li, V. Hoang, C. C. Kao

    Summary Loss of bone mineral density and skeletal muscle area are linked in lung transplant patients. This loss is greater in patients with restrictive compared with obstructive lung diseases. Introduction Sarcopenia and osteoporosis are associated with aging and chronic illnesses and may be linked in patients with advanced lung disease. Pectoralis muscle index (PMI) quantitated on computed tomography (CT) of the chest can be used to measure skeletal muscle mass. This study aimed to determine the relationship of PMI to clinical parameters including bone mineral density (BMD) in candidates for lung transplantation. Methods A retrospective review of transplant candidates at a single center was performed. Demographic, anthropomorphic, and clinical data were recorded. Pectoralis muscle area (PMA) was determined on an axial slice from a chest CT. PMI was calculated as the PMA divided by height squared. BMD was obtained from routine dual-energy X-ray absorptiometry (DXA) scan. Results In 226 included patients, mean PMI was 8.2 ± 3.0 cm2/m2 in males and 6.1 ± 2.1 cm2/m2 in females. Osteopenia was present in 44.4%, and 23.2% of patients had osteoporosis. Patients with obstructive lung disease had lower body mass index (22.0 ± 4.9 versus 27.9 ± 4.9 kg/m2, p < 0.001), PMI (6.0 ± 2.3 versus 8.2 ± 2.8 cm2/m2, p < 0.001), and BMD (− 2.3 ± 1.1 versus − 1.3 ± 1.1, p < 0.001) compared with patients with restrictive lung disease. PMI was a significant predictor of BMD (β = 0.16, p < 0.001). Conclusion The association between muscle area and BMD in lung transplant candidates suggests that similar mechanisms may underlie the development of both. Differences in PMI and BMD in patients with obstructive versus restrictive lung disease may result from differences in respiratory physiology or disease processes.


  • Pleural catheter placement and intrapleural fibrinolysis following lung transplantation

    by Christina C. Kao, Jose F. Cuevas, Sarah Tuthill, Amit D. Parulekar

    Background: This study aimed to investigate the characteristics of lung transplant recipients requiring additional pleural drainage catheters early post–lung transplantation and to determine the safety and efficacy of intrapleural fibrinolytics in these patients.Methods: A retrospective review of lung transplant recipients at a single center was performed. Patient and transplant characteristics, placement of pleural drainage catheters within 90 days of transplant, and use of intrapleural fibrinolytics were determined.Results: Out of 128 patients who underwent lung transplantation, 54 patients required 86 additional chest tubes, the majority of which were size 14 French or smaller. Pleural effusion was the most common indication for tube placement. Patients who required additional chest tubes were more likely to have chronic obstructive pulmonary disease than those who did not. Use of intrapleural fibrinolytics led to radiographic improvement in 77.8% of patients and was not associated with bleeding, pneumothorax, or mortality within 30 days.Conclusions: Use of small‐bore chest tubes and intrapleural fibrinolytics can be safe and effective in lung transplant recipients with persistent pleural effusions.


  • The Microbiome, Intestinal Function, and Arginine Metabolism of Healthy Indian Women Are Different from Those of American and Jamaican Women

    by Christina C Kao, Julia L Cope, Jean W Hsu, Pratibha Dwarkanath, Jeffrey M Karnes, Ruth A Luna, Emily B Hollister, Minerva M Thame, Anura V Kurpad, Farook Jahoor

    Background: Indian women have slower arginine flux during pregnancy compared with American and Jamaican women. Arginine is a semi-essential amino acid